Experienced in WT1-Related Wilms Tumor Syndromes

Dr. John T. Reynolds

Hematology Oncology | Hematology | Oncology
Sky Lakes Medical Center Inc
2610 Uhrmann Rd, 
Klamath Falls, OR 
Clinical Trials:Currently Recruiting for 1 Trial
Accepting New Patients

Experienced in WT1-Related Wilms Tumor Syndromes
Sky Lakes Medical Center Inc
2610 Uhrmann Rd, 
Klamath Falls, OR 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

John Reynolds is a Hematologist Oncology specialist and a Hematologist in Klamath Falls, Oregon. Dr. Reynolds is rated as an Experienced provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. His top areas of expertise are Adult Immune Thrombocytopenia, Hemangioma Thrombocytopenia Syndrome, Thrombocytopenia, Familial Colorectal Cancer, and Bone Marrow Aspiration. Dr. Reynolds is currently accepting new patients.

His clinical research consists of co-authoring 1 peer reviewed article and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Hematology Oncology
Hematology
Oncology
Licenses
Internal Medicine in ND
Hospital Affiliations
Modoc Medical Center
Sky Lakes Medical Center
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

ATRIO Health
  • MEDICARE MAPD
  • MEDICARE SNP
  • OTHER MEDICARE PART D
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medica
  • EPO
  • HMO
  • PPO
Northern Plains Alliance
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE PDP
Sanford Health
  • HMO
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
View 4 Less Insurance Carriers -

Locations

SKY LAKES MEDICAL CENTER INC
2610 Uhrmann Rd, Klamath Falls, OR 97601
Call: 541-274-6262

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


3 Clinical Trials

Targeted Agent and Profiling Utilization Registry (TAPUR) Study
Targeted Agent and Profiling Utilization Registry (TAPUR) Study
Enrollment Status: Recruiting
Publish Date: August 26, 2025
Intervention Type: Drug
Study Drugs: Crizotinib, Palbociclib, Sunitinib, Temsirolimus, Trastuzumab and Pertuzumab, Vemurafenib and Cobimetinib, Regorafenib, Olaparib, Pembrolizumab, Nivolumab and Ipilimumab, Abemaciclib, Afatinib, Talazoparib, Atezolizumab and PHESGO, Atezolizumab and Talazoparib, Entrectinib, Larotrectinib, Tucatinib plus Trastuzumab Subcutaneous (SC)
Study Phase: Phase 2
Phase Ib Study of Pembrolizumab in Combination With Chemo Radiotherapy (CRT) for Locally-advanced Squamous Cell Carcinoma of the Head and Neck (SCCHN)
Phase Ib Study of Pembrolizumab in Combination With Chemo Radiotherapy (CRT) for Locally-advanced Squamous Cell Carcinoma of the Head and Neck (SCCHN)
Enrollment Status: Completed
Publish Date: October 07, 2025
Intervention Type: Radiation, Drug
Study Drugs: Pembrolizumab, Cisplatin
Study Phase: Phase 1
A Randomized, Open-Label, Phase 3 Study of Abemaciclib Combined With Standard Adjuvant Endocrine Therapy Versus Standard Adjuvant Endocrine Therapy Alone in Patients With High Risk, Node Positive, Early Stage, Hormone Receptor Positive, Human Epidermal Receptor 2 Negative, Breast Cancer
A Randomized, Open-Label, Phase 3 Study of Abemaciclib Combined With Standard Adjuvant Endocrine Therapy Versus Standard Adjuvant Endocrine Therapy Alone in Patients With High Risk, Node Positive, Early Stage, Hormone Receptor Positive, Human Epidermal Receptor 2 Negative, Breast Cancer
Enrollment Status: Active_not_recruiting
Publish Date: April 20, 2025
Intervention Type: Drug
Study Drugs: Abemaciclib, Standard Adjuvant Endocrine Therapy
Study Phase: Phase 3
View 2 Less Clinical Trial

1 Total Publications

Irradiation of donor mononuclear cells for treatment of chemorefractory metastatic solid cancers: a community-based immune transplant pilot study.
Irradiation of donor mononuclear cells for treatment of chemorefractory metastatic solid cancers: a community-based immune transplant pilot study.
Journal: Cancer research and treatment
Published: March 08, 2012
Similar Doctors
Distinguished in WT1-Related Wilms Tumor Syndromes
Dr. Mujahid A. Rizvi
Hematology Oncology | Hematology | Oncology
Distinguished in WT1-Related Wilms Tumor Syndromes
Dr. Mujahid A. Rizvi
Hematology Oncology | Hematology | Oncology

Asante

2825 E Barnett Rd, 
Medford, OR 
 (53.7 miles away)
541-789-7000
Languages Spoken:
English, Hindi, Urdu
See accepted insurances
Accepting New Patients
Offers Telehealth

Mujahid Rizvi is a Hematologist Oncology specialist and a Hematologist in Medford, Oregon. Dr. Rizvi is rated as a Distinguished provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. His top areas of expertise are Appendix Cancer, Reticuloendotheliosis, Hairy Cell Leukemia (HCL), Lynch Syndrome, and Bone Marrow Aspiration. Dr. Rizvi is currently accepting new patients.

Advanced in WT1-Related Wilms Tumor Syndromes
Dr. Deepika Wali
Oncology
Advanced in WT1-Related Wilms Tumor Syndromes
Dr. Deepika Wali
Oncology

Sky Lakes Medical Center Inc

2610 Uhrmann Rd, 
Klamath Falls, OR 
 (0.1 miles away)
541-274-6262
Languages Spoken:
English, Hindi
See accepted insurances
Accepting New Patients

Deepika Wali is an Oncologist in Klamath Falls, Oregon. Dr. Wali is rated as a Distinguished provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. Her top areas of expertise are Pleuropulmonary Blastoma, Lung Cancer, Familial Colorectal Cancer, and Small Cell Lung Cancer (SCLC). Dr. Wali is currently accepting new patients.

Advanced in WT1-Related Wilms Tumor Syndromes
Dr. Mihaela C. Matei
Hematology Oncology | Hematology | Oncology
Advanced in WT1-Related Wilms Tumor Syndromes
Dr. Mihaela C. Matei
Hematology Oncology | Hematology | Oncology

Sky Lakes Medical Center Inc

2610 Uhrmann Rd, 
Klamath Falls, OR 
 (0.1 miles away)
541-274-6262
Languages Spoken:
English
See accepted insurances

Mihaela Matei is a Hematologist Oncology specialist and a Hematologist in Klamath Falls, Oregon. Dr. Matei is rated as a Distinguished provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. Her top areas of expertise are Paget Disease of the Breast, Breast Cancer, Pleuropulmonary Blastoma, Reticuloendotheliosis, and Bone Marrow Aspiration.

VIEW MORE WT1-RELATED WILMS TUMOR SYNDROMES DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Reynolds's expertise for a condition
ConditionClose
      • Advanced
      • Adult Immune Thrombocytopenia
        Dr. Reynolds is
        Advanced
        . Learn about Adult Immune Thrombocytopenia.
        See more Adult Immune Thrombocytopenia experts
      • ALK-Positive Non-Small Cell Lung Cancer
        Dr. Reynolds is
        Advanced
        . Learn about ALK-Positive Non-Small Cell Lung Cancer.
        See more ALK-Positive Non-Small Cell Lung Cancer experts
      • Breast Cancer
        Dr. Reynolds is
        Advanced
        . Learn about Breast Cancer.
        See more Breast Cancer experts
      • Childhood Iron Deficiency Anemia
        Dr. Reynolds is
        Advanced
        . Learn about Childhood Iron Deficiency Anemia.
        See more Childhood Iron Deficiency Anemia experts
      • Chronic B-Cell Leukemia (CBCL)
        Dr. Reynolds is
        Advanced
        . Learn about Chronic B-Cell Leukemia (CBCL).
        See more Chronic B-Cell Leukemia (CBCL) experts
      • Chronic Lymphocytic Leukemia (CLL)
        Dr. Reynolds is
        Advanced
        . Learn about Chronic Lymphocytic Leukemia (CLL).
        See more Chronic Lymphocytic Leukemia (CLL) experts
      View All 24 Advanced Conditions
      • Experienced
      • Adult Soft Tissue Sarcoma
        Dr. Reynolds is
        Experienced
        . Learn about Adult Soft Tissue Sarcoma.
        See more Adult Soft Tissue Sarcoma experts
      • Agranulocytosis
        Dr. Reynolds is
        Experienced
        . Learn about Agranulocytosis.
        See more Agranulocytosis experts
      • Alveolar Soft Part Sarcoma
        Dr. Reynolds is
        Experienced
        . Learn about Alveolar Soft Part Sarcoma.
        See more Alveolar Soft Part Sarcoma experts
      • Anal Cancer
        Dr. Reynolds is
        Experienced
        . Learn about Anal Cancer.
        See more Anal Cancer experts
      • Anemia
        Dr. Reynolds is
        Experienced
        . Learn about Anemia.
        See more Anemia experts
      • Angiosarcoma
        Dr. Reynolds is
        Experienced
        . Learn about Angiosarcoma.
        See more Angiosarcoma experts
      View All 112 Experienced Conditions
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile
      For Patients
      • Our Story
      • How MediFind Works
      • Conditions A-Z
      • Doctor Directory
      • Symptoms Directory
      • Procedures Directory
      • Treatment Directory
      • Drug Directory
      • Infusion Center Finder
      • FAQ
      • Contact Us
      For Providers and Practices
      • Claim Your Profile
      • Newsroom
      Business Solutions
      • Provider
      • Network Solutions
      Additional Resources
      • Consumer Health Data Privacy Policy
      • Privacy Policy
      • Terms of Use
      • Advertising Policy
      • Content Policy
      Subscribe to our newsletter

      Sign up to stay informed about MediFind and get wellness sent your way.

      Close

        By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

        Bullet PinMediFind
        Follow us on
        This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
        © 2025 All Rights Reserved